Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,068 | 983 | 242 | 0 | 0 |
| Cost of Goods | 631 | 408 | 97 | N/A | N/A |
| Gross Profit | 437 | 575 | 145 | N/A | N/A |
| Operating Expenses | 5,810 | 5,606 | 4,266 | 3,730 | 3,847 |
| Operating Income | -4,742 | -4,623 | -4,024 | -3,730 | -3,847 |
| Interest Expense | 233 | 0 | 0 | 0 | 0 |
| Other Income | 3,531 | 4,992 | -1,866 | -13,851 | -1,673 |
| Pre-tax Income | -1,444 | 369 | -5,890 | -17,581 | -5,520 |
| Net Income Continuous | -1,444 | 369 | -5,890 | -17,581 | -5,520 |
| Net Income | $-1,430 | $361 | $-5,890 | $-17,581 | $-5,512 |
| EPS Basic Total Ops | -0.04 | 0.25 | -0.27 | -0.98 | -0.34 |
| EPS Basic Continuous Ops | -0.04 | 0.24 | -0.26 | -0.98 | -0.34 |
| EPS Diluted Total Ops | -0.04 | 0.25 | -0.27 | -0.98 | -0.34 |
| EPS Diluted Continuous Ops | -0.04 | 0.24 | -0.26 | -0.98 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.04 | 0.19 | -0.18 | -0.98 | -0.34 |
| EBITDA(a) | $-4,577 | $-4,523 | $-4,024 | $-3,730 | $-3,846 |